General Industrial Machinery Stocks Q3 Results: Benchmarking John Bean (NYSE:JBT)
Looking back on general industrial machinery stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including John Bean (NYSE:JBT) and its peers.
3 Reasons to Sell CZR and 1 Stock to Buy Instead
Shareholders of Caesars Entertainment would probably like to forget the past six months even happened. The stock dropped 30.2% and now trades at $28.10. This may have investors wondering how to approach the situation.
3 Reasons to Avoid LUMN and 1 Stock to Buy Instead
Lumen’s stock price has taken a beating over the past six months, shedding 20.5% of its value and falling to $5.07 per share. This may have investors wondering how to approach the situation.
Q4 Earnings Highs And Lows: Couchbase (NASDAQ:BASE) Vs The Rest Of The Data Storage Stocks
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Couchbase (NASDAQ:BASE) and its peers.
3 Reasons CSCO is Risky and 1 Stock to Buy Instead
Over the past six months, Cisco has been a great trade. While the S&P 500 was flat, the stock price has climbed by 20.2% to $60.80 per share. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
3 Reasons to Sell PACB and 1 Stock to Buy Instead
Shareholders of PacBio would probably like to forget the past six months even happened. The stock dropped 35.2% and now trades at $1.25. This was partly due to its softer quarterly results and might have investors contemplating their next move.
Q4 Earnings Highlights: Cummins (NYSE:CMI) Vs The Rest Of The Heavy Transportation Equipment Stocks
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the heavy transportation equipment industry, including Cummins (NYSE:CMI) and its peers.
3 Reasons to Avoid UDMY and 1 Stock to Buy Instead
Since September 2024, Udemy has been in a holding pattern, posting a small return of 2.9% while floating around $8.17.
3 Reasons to Sell VSTS and 1 Stock to Buy Instead
Over the last six months, Vestis’s shares have sunk to $12.66, producing a disappointing 16.7% loss while the S&P 500 was flat. This may have investors wondering how to approach the situation.
Unpacking Q4 Earnings: BeautyHealth (NASDAQ:SKIN) In The Context Of Other Personal Care Stocks
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the personal care industry, including BeautyHealth (NASDAQ:SKIN) and its peers.